Detalhe da pesquisa
1.
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission.
Blood
; 143(19): 1931-1936, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38364112
2.
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy.
Blood
; 143(4): 336-341, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647641
3.
Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML.
Blood
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38691678
4.
Overlapping features of therapy-related and de novo NPM1-mutated AML.
Blood
; 141(15): 1846-1857, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36508705
5.
Allogeneic haemopoietic cell transplant services in Australia and New Zealand in the first year of the COVID-19 pandemic: a report from Australia and New Zealand transplant and cellular therapies.
Intern Med J
; 53(3): 323-329, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833788
6.
Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis.
Intern Med J
; 53(11): 1979-1986, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878730
7.
Epstein-Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes.
Curr Opin Infect Dis
; 34(6): 635-645, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34751183
8.
Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre-transplant predictors of survival, reactivation, and spontaneous clearance.
Transpl Infect Dis
; 23(3): e13548, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33342000
9.
Dynamics of Epstein-Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant.
Transpl Infect Dis
; 23(5): e13719, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34453768
10.
Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG.
Biol Blood Marrow Transplant
; 26(10): 1868-1875, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32640314
11.
Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome.
Blood
; 140(22): 2407-2411, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35960851
12.
Talaromyces marneffei and dysplastic neutrophils on blood smear in newly diagnosed HIV.
Blood
; 131(2): 269, 2018 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29326352
13.
Chronic myeloproliferative neoplasm in adulthood in CBL syndrome harboring a splice-site CBL variant alongside a novel constitutional CSF3R variant.
EJHaem
; 5(2): 397-402, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38633130
14.
Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies.
Transplant Cell Ther
; 30(3): 334.e1-334.e7, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38029962
15.
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations.
J Clin Oncol
; 42(10): 1158-1168, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215358
16.
Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML.
Blood Adv
; 8(2): 343-352, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039513
17.
Severe hemolysis and transfusion reactions after treatment with BGB-3111 and PD-1 antibody for Waldenström macroglobulinemia.
Haematologica
; 103(5): e223-e225, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29439186
18.
Tattoo Pigment-Induced Granulomatous Lymphadenopathy Mimicking Lymphoma.
Ann Intern Med
; 167(11): 830-831, 2017 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28973364
19.
A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial.
Blood Adv
; 7(16): 4539-4549, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171402
20.
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML.
Leukemia
; 37(10): 2066-2072, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558736